Difference between revisions of "Team:DTU-Denmark"
| Line 5: | Line 5: | ||
| − | |||
<link href="/Team:DTU-Denmark/bootstrapcss?action=raw&ctype=text/css" rel="stylesheet"> | <link href="/Team:DTU-Denmark/bootstrapcss?action=raw&ctype=text/css" rel="stylesheet"> | ||
<link href="/Team:DTU-Denmark/font-awesomecss?action=raw&ctype=text/css" rel="stylesheet"> | <link href="/Team:DTU-Denmark/font-awesomecss?action=raw&ctype=text/css" rel="stylesheet"> | ||
| Line 11: | Line 10: | ||
<link href="/Team:DTU-Denmark/timelinecss?action=raw&ctype=text/css" rel="stylesheet"> | <link href="/Team:DTU-Denmark/timelinecss?action=raw&ctype=text/css" rel="stylesheet"> | ||
<link href="/Team:DTU-Denmark/menufixcss?action=raw&ctype=text/css" rel="stylesheet"> | <link href="/Team:DTU-Denmark/menufixcss?action=raw&ctype=text/css" rel="stylesheet"> | ||
| + | <link href="/Team:DTU-Denmark/loadphpcss?action=raw&ctype=text/css" rel="stylesheet"> | ||
| Line 38: | Line 38: | ||
<nav class="navbar navbar-default navbar-fixed-top" role="navigation"> | <nav class="navbar navbar-default navbar-fixed-top" role="navigation"> | ||
<!-- Brand and toggle get grouped for better mobile display --> | <!-- Brand and toggle get grouped for better mobile display --> | ||
| − | <div class="container"> | + | <div class="container-fluid"> |
<div class="navbar-header"> | <div class="navbar-header"> | ||
<button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#nav-collapse"> | <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#nav-collapse"> | ||
<span class="sr-only">Toggle navigation</span> | <span class="sr-only">Toggle navigation</span> | ||
<i class="fa fa-bars"></i> | <i class="fa fa-bars"></i> | ||
| − | |||
| − | |||
| − | |||
</button> | </button> | ||
<a class="navbar-brand navimg" href="#"><img src="/wiki/images/b/b7/DTU-Denmark_dtulogo.png"></a> | <a class="navbar-brand navimg" href="#"><img src="/wiki/images/b/b7/DTU-Denmark_dtulogo.png"></a> | ||
</div> | </div> | ||
| − | |||
<!-- Collect the nav links, forms, and other content for toggling --> | <!-- Collect the nav links, forms, and other content for toggling --> | ||
<div class="collapse navbar-collapse" id="nav-collapse"> | <div class="collapse navbar-collapse" id="nav-collapse"> | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
<ul class="nav nav-justified"> | <ul class="nav nav-justified"> | ||
| Line 105: | Line 82: | ||
</li> | </li> | ||
| − | + | <li class="hidden-xs"> | |
| − | + | <a href="http://facebook.com/dtubiobuilders" data-toggle="tooltip" data-placement="bottom" title="Follow us on Facebook"> | |
| − | <li> | + | <i class="fa fa-facebook"></i><span class="visible-xs"> Follow us on Facebook</span> |
| + | </a> | ||
| + | </li> | ||
| + | <li class="visible-xs"><a href="http://facebook.com/dtubiobuilders"><i class="fa fa-facebook-square"></i> Follow us on Facebook</a></li> | ||
| + | <li class="hidden-xs"> | ||
| + | <a href="https://twitter.com/IGEM_DTU" data-toggle="tooltip" data-placement="bottom" title="Follow us on Twitter"> | ||
| + | <i class="fa fa-twitter"></i> | ||
| + | </a> | ||
| + | </li> | ||
| + | <li class="visible-xs"><a href="https://twitter.com/IGEM_DTU"><i class="fa fa-twitter-square"></i> Follow us on Twitter</a></li> | ||
| + | <li class="hidden-lg"> | ||
<a href="https://igem.org" target="_blank" class="navimg"> | <a href="https://igem.org" target="_blank" class="navimg"> | ||
<img src="/wiki/images/a/af/DTU-Denmark_igemlogo.png"> | <img src="/wiki/images/a/af/DTU-Denmark_igemlogo.png"> | ||
</a> | </a> | ||
</li> | </li> | ||
| − | |||
| − | |||
</ul> | </ul> | ||
</div><!-- /.navbar-collapse --> | </div><!-- /.navbar-collapse --> | ||
| Line 119: | Line 104: | ||
</nav> | </nav> | ||
<nav class="navbar navbar-default extrabar hidden-xs hidden" data-spy="affix"> | <nav class="navbar navbar-default extrabar hidden-xs hidden" data-spy="affix"> | ||
| − | <div class="container" id="scrollspy"> | + | <div class="container-fluid" id="scrollspy"> |
<ul class="nav nav-justified"> | <ul class="nav nav-justified"> | ||
<li><a class="page-scroll" href="#Project-description">Project description</a></li><li><a class="page-scroll" href="#Social-Media">Social Media</a></li><li><a class="page-scroll" href="#Overview">Overview</a></li><li><a class="page-scroll" href="#Sitemap">Sitemap</a></li> | <li><a class="page-scroll" href="#Project-description">Project description</a></li><li><a class="page-scroll" href="#Social-Media">Social Media</a></li><li><a class="page-scroll" href="#Overview">Overview</a></li><li><a class="page-scroll" href="#Sitemap">Sitemap</a></li> | ||
| Line 131: | Line 116: | ||
</a> | </a> | ||
</div> | </div> | ||
| − | <div class="container"> | + | <div class="container-fluid"> |
<div class="row hero-text"> | <div class="row hero-text"> | ||
<div class="col-md-12"> | <div class="col-md-12"> | ||
Revision as of 16:10, 14 September 2015
Project description
Tune in and listen to The Synthesizers podcast explaining our project in 20 seconds, 5 minutes, or 10 minutes
Non-ribosomal peptides have important anti-bacterial, anti-cancer, and immunosuppressive biological activities. They are synthesized by modular, high molecular weight enzymes that assemble more than 500 different amino acid substrates in an assembly line manner. For this reason, synthetic biologists have tried to engineer these proteins and to switch modules to create analogs and novel natural products, but with little success. Despite being modular, the interactions between modules have evolved to be highly specific, making synthetic Non-Ribosomal Peptide Synthases (NRPS) a challenge to engineer. Instead of switching modules we introduced a recombination system targeting oligo integration in Bacillus subtilis. We used the recombineering system to alter the active sites determining substrate specificity, thereby creating variants of antibiotics. Our focus was the tyrocidine antibiotic, which cannot be used intravenously due to its toxicity. Our goal is to create new analogs through multiplex automated genome engineering to reduce toxicity.
Overview
Overview stuff
Sitemap
TODO
